Shopping Cart

IO Biotech ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SKU
GDPH2477045D
READ MORE
USD 250
Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750
IO Biotech ApS (IO Biotech) is a clinical stage biotechnology company, which develops disruptive immune modulating anti-cancer medicines.
READ MORE
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Summary

IO Biotech ApS (IO Biotech) is a clinical stage biotechnology company, which develops disruptive immune modulating anti-cancer medicines. The company developed a pipeline of first-in-class anti-cancer drugs harnessing a unique technology platform, T-Win. IO Biotech's immuno-oncology therapies target both tumor cells and immune-suppressive cells to enhance their therapeutic effect in cancer treatment. Its pipeline product portfolio includes IO101, and IO102, IDO-derived peptide vaccines indicated for non-small-cell lung carcinoma (NSCLC) and melanoma; IO130, a TDO-derived peptide vaccine against solid tumors; IO103 containing PD-L1-derived peptide targeting myeloma and follicular lymphoma. The company is a spin off from Centre for Cancer Immune Therapy (CCIT), University of Copenhagen Herlev Hospital. IO Biotech is headquartered in Copenhagen, Denmark.

IO Biotech ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

IO Biotech ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

IO Biotech ApS, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

IO Biotech Raises USD12 Million in Series A Financing 10

IO Biotech Raises Funds in Seed Financing 11

Partnerships 12

IO Biotech Enters into Clinical Trial Collaboration Agreement with Merck 12

IO Biotech ApS - Key Competitors 13

IO Biotech ApS - Key Employees 14

IO Biotech ApS - Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Corporate Communications 16

Jun 06, 2018: IO Biotech Names Kathleen Sereda Glaub As Board Director 16

Appendix 17

Methodology 17

About GlobalData 17

Contact Us 17

Disclaimer 17


List Of Figure

List of Figures

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

IO Biotech ApS, Pharmaceuticals & Healthcare, Key Facts 2

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

IO Biotech ApS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

IO Biotech ApS, Deals By Therapy Area, 2012 to YTD 2018 8

IO Biotech ApS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

IO Biotech Raises USD12 Million in Series A Financing 10

IO Biotech Raises Funds in Seed Financing 11

IO Biotech Enters into Clinical Trial Collaboration Agreement with Merck 12

IO Biotech ApS, Key Competitors 13

IO Biotech ApS, Key Employees 14

To know more information on Purchase by Section, please send a mail to

Products

IO Biotech ApS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Brand Description
History Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.